Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP253 (RN7SK pseudogene 253) is a pseudogene related to the gene encoding 7SK small nuclear RNA, a non-coding RNA that functions as a key regulator of transcription elongation by controlling the activity of the P-TEFb kinase complex[2][1][3]. The functional 7SK RNA is involved in pathways critical for neuron development, gene regulation, and possibly disease, but RN7SKP253 itself is not functionally characterized and is classified as a pseudogene—a non-functional genomic segment similar to a gene but typically lacking biological activity[2]. There is currently no evidence that RN7SKP253 is a receptor, enzyme, transporter, or other canonical therapeutic target, nor is there evidence for its role in human disease, drug interactions, clinical biomarkers, or safety concerns[2][5]. Information is limited or lacking regarding any biological or pharmacological functions of this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 253 (RN7SKP253).